BioSpace News Archive

The National Capital Consortium for Pediatric Device Innovation (NCC-PDI), in collaboration with MedTech Innovator, is now accepting applications for its showcase pitch event on March 23, 2020 in College Park, Maryland.

Mercaptor Discoveries (Mercaptor), a company developing therapeutic agents active exclusively at the site of injury, announced the advancement of its preclinical program in epilepsy.

Bolt Biotherapeutics, Inc., a private biotechnology company focused on using its Immune-Stimulating Antibody Conjugate (ISAC) platform technology to unleash the power of the immune system to treat cancer, today announced the addition of Priti Hegde, Ph.D., to its scientific advisory board

QuVa Pharma, Inc. today announced an expanded partnership with Smiths Medical to increase production capacity for pre-filled CADD® medication cassette reservoirs.

The Breakthrough Devices Program is designed to give patients and health care providers timely access to medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.

Enhancing Drug Development for International Pharma Companies and Chinese Biotechs

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue and adjusted EBITDA estimate for the fourth quarter 2019.

Total Series B Raise of $35 million

America’s Largest Independent Kidney Patient Organization Recognizes Top Professionals

NextGen Healthcare, Inc., a leading provider of ambulatory-focused technology solutions, will release its fiscal 2020 third quarter ended December 31, 2019 operating results on Thursday, January 23, 2020 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.